The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.

And while Trump has criticized Ireland for attracting big pharma companies, he’s also suggested he wants to reshore ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

European pharma companies warned the European Commission president at a meeting on Tuesday that U.S. tariffs would expedite ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Shares of several major pharmaceutical companies slumped Wednesday morning as President Donald Trump threatened tariffs on ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

Aurobindo Pharma said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg.

Global drugmakers' stocks dropped across the board after U.S. President Donald Trump reiterated plans for a "major" tariff on ...